1. Home
  2. PRK vs ZLAB Comparison

PRK vs ZLAB Comparison

Compare PRK & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park National Corporation

PRK

Park National Corporation

N/A

Current Price

$177.93

Market Cap

3.2B

Sector

Finance

ML Signal

N/A

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$25.53

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRK
ZLAB
Founded
1908
2013
Country
United States
China
Employees
1694
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.6B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
PRK
ZLAB
Price
$177.93
$25.53
Analyst Decision
Hold
Strong Buy
Analyst Count
5
11
Target Price
★ $199.50
$33.48
AVG Volume (30 Days)
76.2K
★ 989.1K
Earning Date
10-26-2026
11-05-2026
Dividend Yield
★ 2.45%
N/A
EPS Growth
19.21
★ 38.46
EPS
★ 8.77
N/A
Revenue
★ $664,421,000.00
$460,156,000.00
Revenue This Year
$24.03
N/A
Revenue Next Year
$3.17
$26.74
P/E Ratio
$32.40
★ N/A
Revenue Growth
2.92
★ 15.33
52 Week Low
$149.06
$15.96
52 Week High
$215.00
$27.50

Technical Indicators

Market Signals
Indicator
PRK
ZLAB
Relative Strength Index (RSI) 46.77 58.32
Support Level $168.61 $24.24
Resistance Level $186.55 $26.64
Average True Range (ATR) 5.49 1.25
MACD 0.22 0.14
Stochastic Oscillator 47.27 88.19

Price Performance

Historical Comparison
PRK
ZLAB

About PRK Park National Corporation

Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. The company provides the following principal services: the acceptance of deposits for demand, savings and time accounts; commercial, industrial, consumer and real estate lending, including installment loans, credit cards (which are largely offered through a third party), home equity lines of credit and commercial leasing; trust and wealth management services; cash management; safe deposit operations; electronic funds transfers; and a variety of additional banking-related services.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: